DRDiego dos Santos Reis

Diego dos Santos Reis

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Diego dos Santos Reis has a total of 50 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Subacute exposure to a commercial S-metolachlor/flumioxazin formulation induces systemic, genotoxic, and redox alterations in Wistar rats

    by Susy Ricardo Lemes Pontes, Diego dos Santos Reis, Bruna Marques Rodrigues, Ana Luísa Guimarães Santiago, Wilson de Melo Cruvinel, Jamira Dias Rocha, Renata Karine de Carvalho, Vitória Karolina Brandão Souza, Isabella Aguiar Silva, Héricles M. Mesquita, et al.

  • Cytotoxic but not genotoxic: toxicological evaluation of the herbicide mixture S-metolachlor + flumioxazin in human cells, rodents, and bacteria

    by Susy Ricardo Lemes Pontes, Jamira Dias Rocha, Diego dos Santos Reis, Rafaela Avelino da Costa, Carlos Filipe Camilo-Cotrim, Abel Vieira de Melo Bisneto, Cátia Lira Do Amaral, Elisa Flávia Luiz Cardoso Bailão, Lee Chen Chen, Virginia Damin, et al.

    Flumioxazin and S-metolachlor are widely used in soybean cultivation and frequently co-occur in the environment due to their persistence. This study investigated the cytotoxic, genotoxic, and mutagenic potential of a commercial formulation containing this herbicide mixture using an integrated in vitro and in vivo approach. Cytotoxicity was assessed in human erythrocytes and lymphocytes, while mutagenicity was evaluated using the Ames test with Salmonella typhimurium strains TA98 and TA100, without metabolic activation. In vivo genotoxicity was examined in Wistar rats orally exposed for 28 days, followed by the comet assay in bone marrow. The mixture induced concentration-dependent cytotoxicity, with significant hemolysis (EC50 0.093 mg/mL) and reduced lymphocyte viability (IC50 0.219 mg/mL). In contrast, no genotoxic alterations were detected in bone marrow comet assay parameters (250, 500, and 1,000 mg/kg), and mutagenic activity was not confirmed according to Ames test criteria (0.06 to 18.90 mg/plate). Collectively, these findings indicate that, although the mixture exhibited marked cytotoxicity in human cells, it did not show detectable genotoxic or mutagenic effects under the specific experimental conditions tested. These conclusions should be interpreted within the limitations of the present study, particularly the use of only TA98 and TA100 strains, the absence of metabolic activation in the Ames test, and the evaluation of bone marrow as the only tissue in the in vivo comet assay. The cytotoxic effects observed at field-dose-derived concentrations suggest the importance of further ecotoxicological evaluations, particularly regarding potential risks to non-target organisms with limited detoxification capacity.

  • Open Access

    Reproductive toxicity induced by a repeated 28-day oral exposure to a commercial mixture of the herbicides S-metolachlor and flumioxazin in male rats

    by Renata K. Carvalho, Diego S. Reis, Ana Luísa G. Santiago, Bruna M. Rodrigues, Jacqueline A. Leite, Walter D. Júnior, Virgínia Damin, Monica L. Andersen, Maingredy R. Souza, Paulo C. Ghedini, et al.


  • Prenatal Safety Evaluation of a Standardized Dry Extract of Eugenia uniflora Leaves: Dissociation between Maternal Toxicity and Fetal Outcomes in Wistar Rats

    by Diego dos Santos Reis, Graziele Alícia Batista Caixeta, Matheus Vinicius Mendes Pereira, Ana Laura Resende Ramos, Érica Beatriz Viveiros da Luz Santos, Anielly Monteiro de Melo, Jamira Dias Rocha, Elisa Flávia Luiz Cardoso Bailão, Wilson de Melo Cruvinel, Joelma Abadia Marciano de Paula, et al.

  • Toxicological Assessment of a Standardized Dry Extract of Zea mays L. (Poaceae) Stigmas During Gestation: Effects on Maternal Parameters and Fetal Outcomes in Wistar Rats

    by Graziele Alícia Batista Caixeta, Diego dos Santos Reis, Kássya Inácio Soares, Isabella de Brito Ramos, Giovanna Helen Lopes Mendes, Pabline Silva Gasparoti, Monatha Nayara Guimarães Teófilo, Jamira Dias Rocha, Luiz Fernando Fróes Fleury, Elisa Flávia Luiz Cardoso Bailão, et al.

    Background: Corn (Zea mays L., Poaceae) stigmas, popularly known as corn silk, have been traditionally used for their diuretic properties and to treat urinary tract disorders and hypertension. Although several studies have reported beneficial effects, such as anti‐inflammatory and antioxidant activities, data on their safety during pregnancy remain limited. This study aimed to evaluate the effects of prenatal treatment with a standardized dry corn silk extract on maternal and fetal toxicity parameters in Wistar rats.Methods: Corn silk was extracted with 41% (v/v) ethanol, concentrated, and spray‐dried. The total flavonoid content was determined by spectrophotometry, and phenolic compounds, including maysin, were analyzed using HPLC‐DAD and HPLC‐ESI‐MS/MS. Pregnant Wistar rats (n = 10/group) received the vehicle or extract doses of 300, 600, or 1200 mg/kg from gestational Day (GD) 0–20. Clinical signs of toxicity, body weight gain, and food and water intake were monitored. On GD 21, blood samples were collected for biochemical analysis. Reproductive performance and genotoxicity were assessed, along with histopathological examinations of selected organs.Results: The extract contained 1.698% flavonoids, including maysin as the predominant one. No clinical signs of toxicity, changes in body weight gain, water and food intake, genotoxicity, histopathological alterations, or biochemical disturbances were observed. However, the 1200 mg/kg dose increased pre‐implantation losses. No external, skeletal, or visceral malformations were detected in fetuses.Conclusions: Under these experimental conditions, the extract did not induce maternal or fetal toxicity. Nevertheless, the 1200 mg/kg dose may interfere with early pregnancy in Wistar rats.

  • Open Access

    Tissue healing changes on wounds in rats after treatment with Hancornia speciosa latex in cream-gel formulation

    by Patrícia Lima D’abadia, Susy Ricardo Lemes, Paulo Roberto de Melo-Reis, Ruy de Souza Lino Júnior, Pablo José Gonçalves, Diego dos Santos Reis, Graziele Alícia Batista Caixeta, Vanessa Cristine Santana Amaral, Luciane Madureira Almeida

    Hancornia speciosa latex has shown pharmacological potential in wound healing processes due to its angiogenic, osteogenic, and anti-inflammatory activities. The aims of this study were to carry out a cream-gel formulation with 5, 10 and 25% of H. speciosa serum latex and to evaluate its potential to stimulate the skin regeneration in rats’ wounds. One hundred and twenty rats were divided into five groups: neutral control with saline (G1), cream-gel based on H. speciosa latex serum at 5% m/v (G2), cream-gel at 15% m/v (G3), cream-gel at 25% m/v (G4), and cream-gel (G5). The animals were euthanized at three, seven, 14 and 21 days after the injury induction, and some parameters were analyzed: wound contraction, necrosis, fibrin, polymorphonuclear and mononuclear infiltrates, fibroblast, angiogenesis, hemorrhage, and collagen. The therapeutic treatment with cream-gel at 15 and 25% is beneficial in the inflammatory phase of healing processes since it increased the angiogenesis and proliferation of mononuclear infiltrations in wounds. Regarding wound contraction, the treatment with cream-gel (5 and 15%) induced a higher rate of contraction in the proliferative phase. The 15% cream-gel formulation stimulated a greater production of collagen in the injured tissues. H. speciosa cream-gel is a low-cost herbal medicine which can aid in tissue repair.